Refractive Errors Clinical Trials
2 recruiting trials for Refractive Errors. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Refractive Errors clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Essilor International (1), The Cleveland Clinic (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Measurements of physiological parameters of the anterior chamber (device, 1 trial), followed by Measurements of the Axial biometry, Optical coherence tomography.
Track Refractive Errors trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Clinical Investigation for a Multifunction Ophthalmic Measurement Device
The purpose of this clinical investigation is to evaluate the clinical utility of a multifunctional measuring device for Ophtalmology. The results of this clinical investigation...
Corneal Elastography and Patient Specific Modeling
The goal of this research is to develop measurement tools and simulation technology for characterizing and predicting individual responses to corneal treatments and for advancing...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Refractive Errors, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Refractive Errors, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Refractive Errors, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.